MedTrace Logo

Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children

NCT01217099 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2010-10-08

No results posted yet for this study

Summary

The purpose of this study is planned to investigate whether small doses of methylprednisolone pulse macrolide therapy can relieve symptoms,chest X-rays faster than macrolide alone therapy for refractory mycoplasma pneumoniae pneumonia(MPP) .

Conditions

  • Refractory Mycoplasma Pneumoniae Pneumonia

Interventions

DRUG

methylprednisolone

treatment patients were iv methylprednisolone pulse azithromycin for 5 days.

DRUG

azithromycin

control patients were iv azithromycin for 5 days.

Sponsors & Collaborators

  • Chongqing Medical University

    lead OTHER

Principal Investigators

  • zhengxiu luo, doctor · Chongqing Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2010-05-31
Completion
2010-05-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01217099 on ClinicalTrials.gov